ReferenceID 6022

Inhibitory Effect of Piceatannol on Streptococcus suis Infection Both in vitro and in vivo

Front Microbiol

Suilysin (SLY) plays a critical role in Streptococcus suis infections making it an ideal target to the combat infection caused by this pathogen. In the present study, we found that piceatannol (PN), a natural compound, i

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
6022
Evidence Id
22612
Core Evidence Id
22612
Source Reference Id
5306
Herb2 Reference Id
HBREF006103
Subject Paper Key
HBIN040152_33329477
Pubmed Id
33329477
Doi
10.3389/fmicb.2020.593588
Paper Title
Inhibitory Effect of Piceatannol on Streptococcus suis Infection Both in vitro and in vivo
Paper Abstract
Suilysin (SLY) plays a critical role in Streptococcus suis infections making it an ideal target to the combat infection caused by this pathogen. In the present study, we found that piceatannol (PN), a natural compound, inhibits pore-formation by blocking the oligomerization of SLY without affecting the growth of S. suis and the expression of SLY. Furthermore, PN alleviated the J774 cell damage and the expression of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) and interleukin-1alpha (IL-1beta) induced by S. suis in vitro. The computational biology and biochemistry results indicated that PN binds to the joint region of D2 and D4 in SLY, and Asn57, Pro58, Pro59, Glu76, Ile379, Glu380, and Glu418 were critical residues involved in the binding. The binding effect between PN and SLY hindered the SLY monomers from forming the oligomers, thereby weakening the hemolytic activity of SLY. This mechanism was also verified by hemolysis analysis and analysis of KA formation after site-specific mutagenesis. Furthermore, PN protected mice from S. suis infections by reducing bacterial colony formation and the inflammatory response in target organs in vivo. These results indicate that PN is a feasible drug candidate to combat S. suis infections.
Journal
Front Microbiol
Publish Year
2020
Experiment Subject
mouse; j774 cell
Experiment Type
Animal & Cell Experiment
Phenotype Related
Streptococcus Suis Infections; Tumor
Paper Title Cn
Paper Title En
Inhibitory Effect of Piceatannol on Streptococcus suis Infection Both in vitro and in vivo
Bilingual Status
semi_complete